0001156039-23-000031.txt : 20230303 0001156039-23-000031.hdr.sgml : 20230303 20230303162801 ACCESSION NUMBER: 0001156039-23-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Penczek Ronald W CENTRAL INDEX KEY: 0001659075 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 23704511 MAIL ADDRESS: STREET 1: 120 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 4 1 wf-form4_167787883238771.xml FORM 4 X0306 4 2023-03-01 0 0001156039 Elevance Health, Inc. ELV 0001659075 Penczek Ronald W 220 VIRGINIA AVENUE INDIANAPOLIS IN 46204 0 1 0 0 CAO & Controller Common Stock 2023-03-01 4 F 0 64 469.03 D 1853 D Common Stock 2023-03-01 4 A 0 214 0 A 2067 D Common Stock 2023-03-01 4 A 0 1195 0 A 3262 D Common Stock 2023-03-02 4 F 0 380 468.78 D 2882 D Employee Stock Option (Right to Buy) 469.03 2023-03-01 4 A 0 819 0 A 2033-03-01 Common Stock 819.0 819 D PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Represents restricted share units. Restrictions lapse as follows: 71 shares each on 3/1/2024 and 3/1/2025 and 72 shares on 3/1/2026. Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Balance includes 3.60 shares acquired on March 25, 2022, 3.67 shares acquired on June 24, 2022, 3.80 shares acquired on September 23, 2022 and 3.46 shares acquired on December 21, 2022 through a dividend reinvestment plan. The option represents a right to purchase a total of 819 shares, and is exercisable in three installments of 273 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. /s/ Kathleen S. Kiefer, Attorney in fact 2023-03-03